Continuous glucose monitoring (CGM) has long been a game-changer for people with type 1 diabetes, but Dexcom is now expanding its reach with Dexcom Stelo. Unlike Dexcom G7, which is designed primarily for people on insulin therapy, Stelo is built specifically for anyone who doesn’t require insulin, including those with pre diabetes and type 2 diabetes, who want deeper insights into their glucose patterns.

What makes Stelo unique is it is sold over-the-counter. This means people can purchase and use it without a prescription, making CGM tech more accessible than ever before. For people who’ve struggled to get insurance coverage or simply want a clear picture of how food, exercise, and lifestyle affect their glucose, this could be a major step forward. Dexcom has also announced Stelo integration with the Oura Ring, allowing users to connect glucose insights with sleep, stress, and activity data — creating a more complete view of overall health.

In my recent conversation with Dexcom, I asked the big questions about Stelo’s design and purpose. The system builds on Dexcom’s proven sensor technology, but it’s tailored for a different audience. By tracking patterns in real-time, Stelo offers actionable insights that can help guide better day-to-day choices—without the need for fingersticks or manual checks.

If you’re living with type 2 diabetes, prediabetes, or are simply curious about how your body responds to food and activity, Stelo could be a tool worth exploring. It represents a future where CGM isn’t just for people on insulin—it’s for anyone who wants to take a more active role in their health.

 Watch the full YouTube episode below or listen to the podcast above for more insights.

Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a physician before making changes to your healthcare.